EFFECT OF UPADACITINIB ON EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Jean-Frédéric Colombel  ¹     David P. Hudesman  ²     Qian Cao  ³     Subrata Ghosh  ⁴     Walter Reinisch  ⁵     Ana Paula Machado De Lacerda  ⁶     Elena Dubcenco     Chirag Doshi     Samuel Anyanwu     Tian Feng     David T. Rubin  ^7    
1 Icahn School of Medicine at Mount Sinai, New York, United States
² NYU Langone Health, New York, NY, United States
³ Sin Run Shaw Hospital, College of Medicine Zhejiang University, Hanzhou, China
⁴ University College Cork, Cork, Ireland
⁵ Medical University of Vienna, Vienna, Austria
⁶ AbbVie Inc., North Chicago, United States
⁷ University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States

Topic
IBD

Session
Meet the giants at the poster (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)